Dr. Richard O'Neil and Megan Tennant (IMAGE)
Caption
Graduate student Megan Tennant and Richard O'Neil, Ph.D., have promising preclinical results of a new way to administer CAR-T-cell therapy that could mean fewer side effects and the possibility of treating more disease types.
Credit
MUSC Hollings Cancer Center
Usage Restrictions
use with credit only
License
Original content